Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mei-Ping Kung

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Brain

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Living Beings

Procedures

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
125
Kung, Hank
43
Hou, Catherine
38
Zhuang, Zhi-Ping
26
Plössl, Karl
21
Mu, M
21
Chumpradit, S
20
Oya, Shunichi
14
Skovronsky, Daniel
11
Meegalla, SK
11
Choi, Seok-Rye
10
Acton, Paul
10
Lee, Virginia M-Y
10
Trojanowski, John
9
Mozley, David
8
Vessotskie, JM

Sign-in to see all Coauthors

Publications

TOP 3
Qu Wenchao; Ploessl Karl; Truong Hong; Kung Mei-Ping; Kung Hank F
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
Kung Hank F; Lieberman Brian P; Zhuang Zhi-Ping; Oya Shunichi; Kung Mei-Ping; Choi Seok Rye; Poessl Karl; Blankemeyer Eric; Hou Catherine; Skovronsky Daniel; Kilbourn Michael
In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
Qu Wenchao; Choi Seok-Rye; Hou Catherine; Zhuang Zhiping; Oya Shunichi; Zhang Wei; Kung Mei-Ping; Manchandra Rajesh; Skovronsky Daniel M; Kung Hank F
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mei-Ping Kung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Qu Wenchao; Ploessl Karl; Truong Hong; Kung Mei-Ping; Kung Hank F
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.
Bioorganic & medicinal chemistry letters 2009;19(13):3382-5.
2008: Kung Hank F; Lieberman Brian P; Zhuang Zhi-Ping; Oya Shunichi; Kung Mei-Ping; Choi Seok Rye; Poessl Karl; Blankemeyer Eric; Hou Catherine; Skovronsky Daniel; Kilbourn Michael
In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
Nuclear medicine and biology 2008;35(8):825-37.
2008: Qu Wenchao; Choi Seok-Rye; Hou Catherine; Zhuang Zhiping; Oya Shunichi; Zhang Wei; Kung Mei-Ping; Manchandra Rajesh; Skovronsky Daniel M; Kung Hank F
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques.
Bioorganic & medicinal chemistry letters 2008;18(17):4823-7.
2008: Kung Mei-Ping; Hou Catherine; Lieberman Brian P; Oya Shunichi; Ponde Datta E; Blankemeyer Eric; Skovronsky Daniel; Kilbourn Michael R; Kung Hank F
In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(7):1171-6.
2008: Wang Julie L; Parhi Ajit K; Oya Shunichi; Lieberman Brian; Kung Mei-Ping; Kung Hank F
2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.
Nuclear medicine and biology 2008;35(4):447-58.
2008: Plössl Karl; Chandra Rajesh; Qu Wenchao; Lieberman Brian P; Kung Mei-Ping; Zhou Rong; Huang Bin; Kung Hank F
A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent.
Nuclear medicine and biology 2008;35(1):83-90.
2008: Lakshmi Balagopal; Kung Mei-Ping; Lieberman Brian; Zhao Jun; Waterhouse Rikki; Kung Hank F
(R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters.
Nuclear medicine and biology 2008;35(1):43-52.
2008: Maezawa Izumi; Hong Hyun-Seok; Liu Ruiwu; Wu Chun-Yi; Cheng R Holland; Kung Mei-Ping; Kung Hank F; Lam Kit S; Oddo Salvatore; Laferla Frank M; Jin Lee-Way
Congo red and thioflavin-T analogs detect Abeta oligomers.
Journal of neurochemistry 2008;104(2):457-68.
2007: Parhi Ajit K; Wang Julie L; Oya Shunichi; Choi Seok-Rye; Kung Mei-Ping; Kung Hank F
2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.
Journal of medicinal chemistry 2007;50(26):6673-84.
2007: Kung Hank F; Kung Mei-Ping; Wey Shiaw-Pyng; Lin Kun-Ju; Yen Tzu-Chen
Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.
Nuclear medicine and biology 2007;34(7):787-9.
2007: Qu Wenchao; Kung Mei-Ping; Hou Catherine; Oya Shunichi; Kung Hank F
Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease.
Journal of medicinal chemistry 2007;50(14):3380-7.
2007: Qu Wenchao; Kung Mei-Ping; Hou Catherine; Jin Lee-Way; Kung Hank F
Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection.
Bioorganic & medicinal chemistry letters 2007;17(13):3581-4.
2007: Chandra Rajesh; Oya Shunichi; Kung Mei-Ping; Hou Catherine; Jin Lee-Way; Kung Hank F
New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques.
Journal of medicinal chemistry 2007;50(10):2415-23.
2007: Qu Wenchao; Kung Mei-Ping; Hou Catherine; Benedum Tyler E; Kung Hank F
Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
Journal of medicinal chemistry 2007;50(9):2157-65.
2007: Kung Mei-Ping; Hou Catherine; Goswami Rajesh; Ponde Datta E; Kilbourn Michael R; Kung Hank F
Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
Nuclear medicine and biology 2007;34(3):239-46.
2007: Kilbourn Michael R; Hockley Brian; Lee Lihsueh; Hou Catherine; Goswami Rajesh; Ponde Datta E; Kung Mei-Ping; Kung Hank F
Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
Nuclear medicine and biology 2007;34(3):233-7.
2007: Oya Shunichi; Choi Seok-Rye; Kung Mei-Ping; Kung Hank F
5-Chloro-2-(2'-((dimethylamino)methyl)-4'-iodophenylthio)benzenamine: a new serotonin transporter ligand.
Nuclear medicine and biology 2007;34(2):129-39.
2007: Stephenson Karin A; Chandra Rajesh; Zhuang Zhi-Ping; Hou Catherine; Oya Shunichi; Kung Mei-Ping; Kung Hank F
Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates.
Bioconjugate chemistry 2007;18(1):238-46.
2007: Zhang Wei; Kung Mei-Ping; Oya Shunichi; Hou Catherine; Kung Hank F
18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Nuclear medicine and biology 2007;34(1):89-97.
2006: Goswami Rajesh; Ponde Datta E; Kung Mei-Ping; Hou Catherine; Kilbourn Mike R; Kung Hank F
Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
Nuclear medicine and biology 2006;33(6):685-94.
2006: Newberg Andrew B; Wintering Nancy A; Plössl Karl; Hochold John; Stabin Michael G; Watson Marianne; Skovronsky Daniel; Clark Christopher M; Kung Mei-Ping; Kung Hank F
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):748-54.
2006: Zhuang Zhi-Ping; Kung Mei-Ping; Kung Hank F
Synthesis of biphenyltrienes as probes for beta-amyloid plaques.
Journal of medicinal chemistry 2006;49(9):2841-4.
2006: Chandra Rajesh; Kung Mei-Ping; Kung Hank F
Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging.
Bioorganic & medicinal chemistry letters 2006;16(5):1350-2.
2006: Hou Catherine; Tu Zhude; Mach Robert; Kung Hank F; Kung Mei-Ping
Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Nuclear medicine and biology 2006;33(2):203-9.
2005: Zhang Wei; Oya Shunichi; Kung Mei-Ping; Hou Catherine; Maier Donna L; Kung Hank F
F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
Nuclear medicine and biology 2005;32(8):799-809.
2005: Kung Mei-Ping; Kung Hank F
Mass effect of injected dose in small rodent imaging by SPECT and PET.
Nuclear medicine and biology 2005;32(7):673-8.
2005: Zhang Wei; Oya Shunichi; Kung Mei-Ping; Hou Catherine; Maier Donna L; Kung Hank F
F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
Journal of medicinal chemistry 2005;48(19):5980-8.
2005: Zhuang Zhi-Ping; Kung Mei-Ping; Hou Catherine; Ploessl Karl; Kung Hank F
Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
Nuclear medicine and biology 2005;32(2):171-84.
2004: Kung Mei-Ping; Hou Catherine; Zhuang Zhi-Ping; Skovronsky Daniel; Kung Hank F
Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Brain research 2004;1025(1-2):98-105.
2004: Kung Hank F; Newman Suzanne; Choi Seok-Rye; Oya Shunichi; Hou Catherine; Zhuang Zhi-Ping; Acton Paul D; Plössl Karl; Winkler Jeffrey; Kung Mei-Ping
2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.
Journal of medicinal chemistry 2004;47(21):5258-64.
2004: Kung Mei-Ping; Hou Catherine; Zhuang Zhi-Ping; Cross Alan J; Maier Donna L; Kung Hank F
Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
European journal of nuclear medicine and molecular imaging 2004;31(8):1136-45.
2004: Kung Mei-Ping; Choi Seok-Rye; Hou Catherine; Zhuang Zhi-Ping; Foulon Catherine; Kung Hank F
Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.
Nuclear medicine and biology 2004;31(5):533-41.
2004: Kung Mei-Ping; Zhuang Zhi-Ping; Hou Cathy; Kung Hank F
Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging.
Journal of molecular neuroscience : MN 2004;24(1):49-53.
2003: Kung Hang F; Kung Mei Ping; Zhuang Zhi Ping; Hou Catherine; Lee Chi-Wan; Plössl Karl; Zhuang Bing; Skovronsky Daniel M; Lee Virginia M-Y; Trojanowski John Q
Iodinated tracers for imaging amyloid plaques in the brain.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2003;5(6):418-26.
2003: Crystal Adam S; Giasson Benoit I; Crowe Alexander; Kung Mei-Ping; Zhuang Zhi-Ping; Trojanowski John Q; Lee Virginia M-Y
A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114.
Journal of neurochemistry 2003;86(6):1359-68.
2003: Lee Chi-Wan; Kung Mei-Ping; Hou Catherine; Kung Hank F
Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain.
Nuclear medicine and biology 2003;30(6):573-80.
2003: Ono Masahiro; Wilson Alan; Nobrega Jose; Westaway David; Verhoeff Paul; Zhuang Zhi-Ping; Kung Mei-Ping; Kung Hank F
11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2003;30(6):565-71.
2003: Kung Mei-Ping; Skovronsky Daniel M; Hou Catherine; Zhuang Zhi-Ping; Gur Tamar L; Zhang Bin; Trojanowski John Q; Lee Virginia M-Y; Kung Hank F
Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Journal of molecular neuroscience : MN 2003;20(1):15-24.
2003: Kung Hank F; Kung Mei-Ping; Choi Seok Rye
Radiopharmaceuticals for single-photon emission computed tomography brain imaging.
Seminars in nuclear medicine 2003;33(1):2-13.
2003: Zhuang Zhi-Ping; Kung Mei-Ping; Wilson Alan; Lee Chi-Wan; Plössl Karl; Hou Catherine; Holtzman David M; Kung Hank F
Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
Journal of medicinal chemistry 2003;46(2):237-43.
2003: Kung Mei-Ping; Zhuang Zhi-Ping; Hou Catherine; Jin Lee-Way; Kung Hank F
Characterization of radioiodinated ligand binding to amyloid beta plaques.
Journal of molecular neuroscience : MN 2003;20(3):249-54.
2002: Acton Paul D; Hou Catherine; Kung Mei-Ping; Plössl Karl; Keeney Cindy L; Kung Hank F
Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.
European journal of nuclear medicine and molecular imaging 2002;29(11):1507-15.
2002: Kung Mei-Ping; Hou Catherine; Zhuang Zhi-Ping; Zhang Bin; Skovronsky Daniel; Trojanowski John Q; Lee Virginia M-Y; Kung Hank F
IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques.
Brain research 2002;956(2):202-10.
2002: Ono Masahiro; Kung Mei-Ping; Hou Catherine; Kung Hank F
Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease.
Nuclear medicine and biology 2002;29(6):633-42.
2002: Kung Mei-Ping; Hou Catherine; Zhuang Zhi-Ping; Skovronsky Daniel M; Zhang Bin; Gur Tamar L; Trojanowski John Q; Lee Virginia M Y; Kung Hank F
Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease.
Journal of molecular neuroscience : MN 2002;19(1-2):7-10.
2002: Acton Paul D; Kung Mei-Ping; Hou Catherine; Plössl Karl; Keeney Cindy; Kung Hank F
Ultra-high resolution single photon emission tomography imaging of the mouse striatum.
European journal of nuclear medicine and molecular imaging 2002;29(3):446.
2001: Kung H F; Lee C W; Zhuang Z P; Kung M P; Hou C; Plössl K
Novel stilbenes as probes for amyloid plaques.
Journal of the American Chemical Society 2001;123(50):12740-1.
2001: Zhuang Z P; Kung M P; Hou C; Plössl K; Skovronsky D; Gur T L; Trojanowski J Q; Lee V M; Kung H F
IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain.
Nuclear medicine and biology 2001;28(8):887-94.
2001: Schmidt M L; Schuck T; Sheridan S; Kung M P; Kung H; Zhuang Z P; Bergeron C; Lamarche J S; Skovronsky D; Giasson B I; Lee V M; Trojanowski J Q
The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains.
The American journal of pathology 2001;159(3):937-43.
2001: Lee C W; Zhuang Z P; Kung M P; Plössl K; Skovronsky D; Gur T; Hou C; Trojanowski J Q; Lee V M; Kung H F
Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain.
Journal of medicinal chemistry 2001;44(14):2270-5.
2001: Zhuang Z P; Kung M P; Hou C; Skovronsky D M; Gur T L; Plössl K; Trojanowski J Q; Lee V M; Kung H F
Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.
Journal of medicinal chemistry 2001;44(12):1905-14.
2000: Stanwood G D; Artymyshyn R P; Kung M P; Kung H F; Lucki I; McGonigle P
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1223-31.
2000: Choi S R; Hou C; Oya S; Mu M; Kung M P; Siciliano M; Acton P D; Kung H F
Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
Synapse (New York, N.Y.) 2000;38(4):403-12.
2000: Skovronsky D M; Zhang B; Kung M P; Kung H F; Trojanowski J Q; Lee V M
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7609-14.
2000: Oya S; Choi S R; Hou C; Mu M; Kung M P; Acton P D; Siciliano M; Kung H F
2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
Nuclear medicine and biology 2000;27(3):249-54.
1999: Xu Y; Choi S R; Kung M P; Kung H F
Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: novel glucose analogs.
Nuclear medicine and biology 1999;26(7):833-9.
1999: Mu M; Kung M P; Plössl K; Acton P D; Mozley P D; Kung H F
A simplified method to determine [99mTc]TRODAT-1 in human plasma.
Nuclear medicine and biology 1999;26(7):821-5.
1999: Acton P D; Kung M P; Mu M; Plössl K; Hou C; Siciliano M; Oya S; Kung H F
Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM.
European journal of nuclear medicine 1999;26(8):854-61.
1999: Kung M P; Hou C; Oya S; Mu M; Acton P D; Kung H F
Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters.
European journal of nuclear medicine 1999;26(8):844-53.
1999: Choi S R; Kung M P; Plössl K; Meegalla S; Kung H F
An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1.
Nuclear medicine and biology 1999;26(4):461-6.
1999: Acton P D; Kushner S A; Kung M P; Mozley P D; Plössl K; Kung H F
Simplified reference region model for the kinetic analysis of [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography.
European journal of nuclear medicine 1999;26(5):518-26.
1999: Dresel S H; Kung M P; Huang X F; Plössl K; Hou C; Meegalla S K; Patselas G; Mu M; Saffer J R; Kung H F
Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):660-6.
1999: Dresel S H; Kung M P; Huang X; Plössl K; Hou C; Shiue C Y; Karp J; Kung H F
In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.
European journal of nuclear medicine 1999;26(4):342-7.
1999: Zhuang Z P; Kung M P; Mu M; Hou C; Kung H F
99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Bioconjugate chemistry 1999;10(2):159-68.
1999: Zhuang Z P; Plössl K; Kung M P; Mu M; Kung H F
Neutral and stereospecific Tc-99m complexes: [99mTc]N-benzyl-3,4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT).
Nuclear medicine and biology 1999;26(2):217-24.
1999: Oya S; Kung M P; Acton P D; Mu M; Hou C; Kung H F
A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.
Journal of medicinal chemistry 1999;42(3):333-5.
1999: Kushner S A; McElgin W T; Kung M P; Mozley P D; Plössl K; Meegalla S K; Mu M; Dresel S; Vessotskie J M; Lexow N; Kung H F
Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):150-8.
1998: Meegalla S K; Plössl K; Kung M P; Stevenson D A; Mu M; Kushner S; Liable-Sands L M; Rheingold A L; Kung H F
Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
Journal of medicinal chemistry 1998;41(4):428-36.
1998: Oya S; Plössl K; Kung M P; Stevenson D A; Kung H F
Small and neutral Tc(v)O BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents.
Nuclear medicine and biology 1998;25(2):135-40.
1998: Zhuang Z P; Kung M P; Mu M; Kung H F
Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
Journal of medicinal chemistry 1998;41(2):157-66.
1998: Dresel S H; Kung M P; Plössl K; Meegalla S K; Kung H F
Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
European journal of nuclear medicine 1998;25(1):31-9.
1997: Vessotskie J M; Kung M P; Chumpradit S; Kung H F
Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(-)5-OH-PIPAT.
Brain research 1997;778(1):89-98.
1997: Vessotskie J M; Kung M P; Chumpradit S; Kung H F
Characterization of [125I]S(-)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines.
Neuropharmacology 1997;36(7):999-1007.
1997: Allen A R; Singh A; Zhuang Z P; Kung M P; Kung H F; Lucki I
The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors.
Pharmacology, biochemistry, and behavior 1997;57(1-2):301-7.
1997: Kung M P; Stevenson D A; Plössl K; Meegalla S K; Beckwith A; Essman W D; Mu M; Lucki I; Kung H F
[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
European journal of nuclear medicine 1997;24(4):372-80.
1997: Shiue C Y; Shiue G G; Mozley P D; Kung M P; Zhuang Z P; Kim H J; Kung H F
P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.
Synapse (New York, N.Y.) 1997;25(2):147-54.
1997: Meegalla S K; Plössl K; Kung M P; Chumpradit S; Stevenson D A; Kushner S A; McElgin W T; Mozley P D; Kung H F
Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
Journal of medicinal chemistry 1997;40(1):9-17.
1997: Kung M P; Stevenson D A; Zhuang Z P; Vessotskie J M; Chumpradit S; Sun X M; Kung H F
Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Life sciences 1997;60(2):91-100.
1996: Mach R H; Nader M A; Ehrenkaufer R L; Line S W; Smith C R; Luedtke R R; Kung M P; Kung H F; Lyons D; Morton T E
Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
Synapse (New York, N.Y.) 1996;24(4):322-33.
1996: Mozley P D; Kim H J; Gur R C; Tatsch K; Muenz L R; McElgin W T; Kung M P; Mu M; Myers A M; Kung H F
Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(12):1965-70.
1996: Kung H F; Frederick D; Kim H J; McElgin W; Kung M P; Mu M; Mozley P D; Vessotskie J M; Stevenson D A; Kushner S A; Zhuang Z P
In vivo SPECT imaging of 5-HT1A receptors with [123I]p-MPPI in nonhuman primates.
Synapse (New York, N.Y.) 1996;24(3):273-81.
1996: Kung H F; Kim H J; Kung M P; Meegalla S K; Plössl K; Lee H K
Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.
European journal of nuclear medicine 1996;23(11):1527-30.
1996: Kung H F; Stevenson D A; Zhuang Z P; Kung M P; Frederick D; Hurt S D
New 5-HT1A receptor antagonist: [3H]p-MPPF.
Synapse (New York, N.Y.) 1996;23(4):344-6.
1996: Oya S; Kung M P; Frederick D; Kung H F
Novel TcVO(III) N2S2 complexes: interconversion by redox reaction.
Nuclear medicine and biology 1996;23(5):589-93.
1996: Meegalla S; Plössl K; Kung M P; Chumpradit S; Stevenson D A; Frederick D; Kung H F
Tc-99m-labeled tropanes as dopamine transporter imaging agents.
Bioconjugate chemistry 1996;7(4):421-9.
1996: Mozley P D; Stubbs J B; Kim H J; McElgin W; Kung M P; Meegalla S; Kung H F
Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):151-9.
1996: Kung M P; Mu M; Zhuang Z P; Kung H F
NCS-MPP (4-(2'-methoxy-phenyl)-1-[2'-(N-2"-pyridyl)-p-isothiocyanobenz amido]-ethyl-piperazine): a high affinity and irreversible 5-HT1A receptor ligand.
Life sciences 1996;58(3):177-86.
1995: Malison R T; Vessotskie J M; Kung M P; McElgin W; Romaniello G; Kim H J; Goodman M M; Kung H F
Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2290-7.
1995: Oya S; Kung M P; Frederick D; Kung H F
New bisaminoethanethiol (BAT) ligands which form two interconvertible Tc-99m complexes.
Nuclear medicine and biology 1995;22(6):749-57.
1995: Kung M P; Essman W D; Frederick D; Meegalla S; Goodman M; Mu M; Lucki I; Kung H F
IPT: a novel iodinated ligand for the CNS dopamine transporter.
Synapse (New York, N.Y.) 1995;20(4):316-24.
1995: Mozley P D; Stubbs J B; Kim H J; McElgin W; Chumpradit S; Kung M P; Romaniello G; Kung H F
Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1322-31.
1995: Vessotskie J M; Kung M P; Chumpradit S; Romaniello G; McElgin W; Frederick D; Malison R T; Kung H F
In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(7):1282-8.
1995: Burris K D; Pacheco M A; Filtz T M; Kung M P; Kung H F; Molinoff P B
Lack of discrimination by agonists for D2 and D3 dopamine receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;12(4):335-45.
1995: Canney D J; Kung M P; Kung H F
Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
Nuclear medicine and biology 1995;22(4):527-35.
1995: Kung M P; Frederick D; Mu M; Zhuang Z P; Kung H F
4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
The Journal of pharmacology and experimental therapeutics 1995;272(1):429-37.
1995: Zhuang Z P; Kung M P; Clarke W; Maayani S; Mu M; Kung H F
Synthesis of (+)-(R)- and (-)-(S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)] aminotetralin: new 5-HT1A receptor ligands.
Chirality 1995;7(6):452-8.
1994: Kung M P; Zhuang Z P; Frederick D; Kung H F
In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.
Synapse (New York, N.Y.) 1994;18(4):359-66.
1994: Zhuang Z P; Kung M P; Chumpradit S; Mu M; Kung H F
Derivatives of 4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl-p-iodobenzamido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands.
Journal of medicinal chemistry 1994;37(26):4572-5.
1994: Kung M P; Chumpradit S; Frederick D; Garner S; Burris K D; Molinoff P B; Kung H F
Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(6):611-7.
1994: Chumpradit S; Kung M P; Vessotskie J; Foulon C; Mu M; Kung H F
Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Journal of medicinal chemistry 1994;37(24):4245-50.
1994: Kung M P; Canney D J; Frederick D; Zhuang Z; Billings J J; Kung H F
Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites.
Synapse (New York, N.Y.) 1994;18(3):225-32.
1994: Francesconi L C; Yang Y Y; Kung M P; Zhang X X; Billings J J; Guo Y Z; Kung H F
Technetium-99m N,N'-bis(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand.
Journal of medicinal chemistry 1994;37(20):3282-8.
1994: Zhuang Z P; Kung M P; Kung H F
Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand.
Journal of medicinal chemistry 1994;37(10):1406-7.
1994: Burris K D; Filtz T M; Chumpradit S; Kung M P; Foulon C; Hensler J G; Kung H F; Molinoff P B
Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle.
The Journal of pharmacology and experimental therapeutics 1994;268(2):935-42.
1994: Garner S E; Kung M P; Foulon C; Chumpradit S; Kung H F
[125I](S)-trans-7-OH-PIPAT: a potential spect imaging agent for sigma binding sites.
Life sciences 1994;54(9):593-603.
1994: Kung H F; Kung M P; Clarke W; Maayani S; Zhuang Z P
A potential 5-HT1A receptor antagonist: p-MPPI.
Life sciences 1994;55(19):1459-62.
1993: Billings J J; Guo Y Z; Kung M P; Kung H F
Localization of IBF as a D-2 dopamine receptor imaging agent in nonhuman primates.
European journal of nuclear medicine 1993;20(12):1146-53.
1993: Chumpradit S; Kung M P; Kung H F
Synthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(26):4308-12.
1993: Zhuang Z P; Kung M P; Kung H F
Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand.
Journal of medicinal chemistry 1993;36(21):3161-5.
1993: Guo Y Z; Kung M P; Cheng H; Pfeiffer N; Mozley D; Kung H F
A simplified method for quantitation of iodine-123 iodobenzamide in human plasma: a technical note.
European journal of nuclear medicine 1993;20(5):373-8.
1993: Foulon C; Kung M P; Kung H F
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Journal of medicinal chemistry 1993;36(10):1499-500.
1993: Kung M P; Kung H F; Chumpradit S; Foulon C
In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
European journal of pharmacology 1993;235(1):165-6.
1993: Chumpradit S; Kung M P; Billings J; Mach R; Kung H F
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Journal of medicinal chemistry 1993;36(2):221-8.
1992: Chumpradit S; Kung M P; Panyachotipun C; Prapansiri V; Foulon C; Brooks B P; Szabo S A; Tejani-Butt S; Frazer A; Kung H F
Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites.
Journal of medicinal chemistry 1992;35(23):4492-7.
1992: Ohmomo Y; Francesconi L; Kung M P; Kung H F
New conformationally restricted 99mTc N2S2 complexes as myocardial perfusion imaging agents.
Journal of medicinal chemistry 1992;35(1):157-62.
1992: Billings J J; Kung M P; Chumpradit S; Mozley D; Alavi A; Kung H F
Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Journal of neurochemistry 1992;58(1):227-36.
1992: Kung M P; Chumpradit S; Billings J; Kung H
4-Iodotomoxetine: a novel ligand for serotonin uptake sites.
Life sciences 1992;51(2):95-106.
1991: Chumpradit S; Kung M P; Billings J J; Kung H F
Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor.
Journal of medicinal chemistry 1991;34(3):877-83.
1991: Kung M P; Liu B L; Yang Y Y; Billings J J; Kung H F
A kit formulation for preparation of iodine-123-IBZM: a new CNS D-2 dopamine receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(2):339-42.
1991: John C S; Kung M P; Billings J; Kung H F
Preparation, radiolabeling and biodistribution of a new class of bisaminothiol (BAT) ligands as possible imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(5):551-6.
1990: Kung H F; Liu B L; Mankoff D; Kung M P; Billings J J; Francesconi L; Alavi A
A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(10):1635-40.
1990: Kung M P; Kung H F; Billings J; Yang Y; Murphy R A; Alavi A
The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):648-54.
1990: Kung H F; Alavi A; Chang W; Kung M P; Keyes J W; Velchik M G; Billings J; Pan S; Noto R; Rausch
In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):573-9.
1990: Murphy R A; Kung H F; Kung M P; Billings J
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Journal of medicinal chemistry 1990;33(1):171-8.
1989: Schonwetter B S; Luedtke R R; Kung M P; Billings J; Kung H F; Molinoff P B
Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
The Journal of pharmacology and experimental therapeutics 1989;250(1):110-6.
1989: Chumpradit S; Kung H F; Billings J; Kung M P; Pan S
(+/-)-7-chloro-8-hydroxy-1-(4'-[125I]iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine: a potential CNS D-1 dopamine receptor imaging agent.
Journal of medicinal chemistry 1989;32(7):1431-5.
1989: Kung H F; Pan S; Kung M P; Billings J; Kasliwal R; Reilley J; Alavi A
In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(1):88-92.
1989: Billings J; Kung M P; Chumpradit S; Pan S; Kung H F
[125I](+/-)FISCH: a new CNS D-1 dopamine receptor imaging ligand.
Life sciences 1989;45(8):711-8.
1988: Kung H F; Kasliwal R; Pan S G; Kung M P; Mach R H; Guo Y Z
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Journal of medicinal chemistry 1988;31(5):1039-43.

Sign-in to see more